Cargando…

NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer

Mutations in Kelch-like ECH-associated protein 1 (KEAP1) cause the aberrant activation of nuclear factor erythroid-derived 2-like 2 (NRF2), which leads to oncogenesis and drug resistance in lung cancer cells. Our study was designed to identify the genes involved in lung cancer progression targeted b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namani, Akhileshwar, Cui, Qin Qin, Wu, Yihe, Wang, Hongyan, Wang, Xiu Jun, Tang, Xiuwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642521/ https://www.ncbi.nlm.nih.gov/pubmed/29050246 http://dx.doi.org/10.18632/oncotarget.19349

Ejemplares similares

Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways
por: Namani, Akhileshwar, et al.
Publicado: (2019)

Systematic Identification of Multi Omics-based Biomarkers in KEAP1 Mutated TCGA Lung Adenocarcinoma
por: Namani, Akhileshwar, et al.
Publicado: (2019)

Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer
por: Namani, Akhileshwar, et al.
Publicado: (2018)

Integrated data analysis reveals significant associations of KEAP1 mutations with DNA methylation alterations in lung adenocarcinomas
por: Elshaer, Mohamed, et al.
Publicado: (2020)

Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice
por: Hammad, Ahmed, et al.
Publicado: (2021)

Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer
por: Wang, Hongyan, et al.
Publicado: (2019)

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021)

Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2
por: Huang, Sha, et al.
Publicado: (2020)

Diverse CBX family members as potential prognostic biomarkers in non‐small‐cell lung cancer
por: Xie, Xiaobin, et al.
Publicado: (2020)

Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
por: Zhao, Jiangang, et al.
Publicado: (2020)

Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
por: Liao, Jipei, et al.
Publicado: (2010)

Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
por: Wang, Qingsong, et al.
Publicado: (2020)

Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer
por: Wang, Ke, et al.
Publicado: (2017)

Identification of prognostic signature of non–small cell lung cancer based on TCGA methylation data
por: Wang, Yifan, et al.
Publicado: (2020)

Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer
por: Chen, Bo, et al.
Publicado: (2019)

Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
por: Xu, Fei, et al.
Publicado: (2022)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Survival-associated alternative splicing signatures in non-small cell lung cancer
por: Zhao, Deze, et al.
Publicado: (2020)

Characteristics of hypoxic tumor microenvironment in non-small cell lung cancer, involving molecular patterns and prognostic signature
por: Huang, Zhanghao, et al.
Publicado: (2021)

ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer
por: Zhang, Binbin, et al.
Publicado: (2021)

Characterizing the Metabolic and Immune Landscape of Non-small Cell Lung Cancer Reveals Prognostic Biomarkers Through Omics Data Integration
por: Wang, Fengjiao, et al.
Publicado: (2021)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Characterizing heterogeneity of non‐small cell lung tumour microenvironment to identify signature prognostic genes
por: Mi, Kai, et al.
Publicado: (2020)

A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer
por: Song, Jia-Yi, et al.
Publicado: (2020)

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer
por: Wang, Nan, et al.
Publicado: (2018)

Identification of a prognostic immune‐related signature for small cell lung cancer
por: Xie, Qi, et al.
Publicado: (2021)

Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer
por: Liu, Yang, et al.
Publicado: (2019)

Prognostic implication of glycolysis related gene signature in non-small cell lung cancer
por: Yao, Jie, et al.
Publicado: (2021)

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort
por: Shen, Fangfang, et al.
Publicado: (2023)

Osteopontin is a prognostic biomarker in non-small cell lung cancer
por: Rud, Ane Kongsgaard, et al.
Publicado: (2013)

Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer
por: Sandfeld-Paulsen, B., et al.
Publicado: (2016)

A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
por: Wang, Zhihao, et al.
Publicado: (2022)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC
por: Li, Qin, et al.
Publicado: (2020)

Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases
por: Zhou, Yuwei, et al.
Publicado: (2022)

Prognostic significance of RelB overexpression in non‐small cell lung cancer patients
por: Qin, Hualong, et al.
Publicado: (2016)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Synthetic Imine Resveratrol Analog 2-Methoxyl-3,6-Dihydroxyl-IRA Ameliorates Colitis by Activating Protective Nrf2 Pathway and Inhibiting NLRP3 Expression
por: Chen, Yeru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_se3qko5qmmv949pon61m5vn1ct